申请人:Accord Healthcare Inc.
公开号:EP2647641A1
公开(公告)日:2013-10-09
The present invention relates to a stereoselective synthesis of novel β-lactam dimers as useful precursors for the preparation of paclitaxel, docetaxel, and analogues thereof. More particularly, the new β-lactams are prepared from readily available and enantiomerically pure chiral auxiliaries. The β-lactams are then reacted with a suitably protected taxane to produce diastereomerically enriched side chain-bearing taxanes. Finally, the chiral auxiliary is cleaved and protecting groups are removed to provide the desired taxane.
本发明涉及一种立体选择性合成新型β-内酰胺二聚体的方法,该方法是制备紫杉醇、多西他赛及其类似物的有用前体。更具体地说,新的β-内酰胺从易得到的对映纯手性助剂中制备而来。然后,β-内酰胺与适当保护的紫杉烷类反应,产生具有对映异构体富集的侧链-含紫杉烷类。最后,剥离手性助剂并去除保护基,从而提供所需的紫杉烷类。